Hindawi / Blog / Blog Post

Latest from our journals

Editor spotlight: Meet Associate Professor Henrik Falhammar

Editors | Researchers
Editor spotlight: Meet Associate Professor Henrik Falhammar

This blog is part of our ‘Editor Spotlight Series’. Look out for monthly posts where our Academic Editors share insights into their roles, tips for authors, and discuss trends within their specialist fields.

Associate Professor Henrik Falhammar is an Academic Editor for Hindawi's  International Journal of Endocrinology. He is a highly respected senior researcher and Senior Consultant Endocrinologist in the Department of Endocrinology, Metabolism and Diabetes at the Karolinska University Hospital, Stockholm, Sweden. He is also affiliated with the Department of Molecular Medicine and Surgery at the Karolinska Institute. Prof Falhammar is a regular contributor to academic papers and is published worldwide in his field of expertise. 

Associate Professor Henrik Falhammar
Henrik Falhammar, Associate Professor and Senior Consultant Endocrinologist Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital
ORCID: 0000-0002-5622-6987 

What is your background and how did you become a researcher in your field?

I was educated at the Karolinska Institute (MD and PhD), and completed my specialist training in Endocrinology and Internal Medicine at the Karolinska University Hospital, both in Stockholm, Sweden. I have worked extensively both clinically and academically in Sweden and Australia. In my clinical work, I encounter many issues where evidence is lacking, and this is the basis of my research in order to improve patient care.  

What attracted you to the position of Academic Editor for International Journal of Endocrinology, and Hindawi as a publisher?

I like conducting research and publishing; from writing, submission, rebuttal, and finally publishing a manuscript – I find the whole process fascinating. When I was offered the position of Academic Editor for International Journal of Endocrinology, I accepted because I want to help others get their work improved and published. Hindawi as a publisher is growing and improving all the time and is now a major player. To me, Open Access makes sense, because it makes research available for everyone involved.

Why is this journal important for the field? What is its relevance to society?

Hindawi’s International Journal of Endocrinology publishes in all fields of endocrinology, both basic and clinical research. The field of Endocrinology is extremely broad and so much research is being done with new knowledge being created all the time, which needs to be spread around the world. 

What advice would you give to a PhD researcher trying to write their first article?

I have come across some very impressive research in International Journal of Endocrinology, but sometimes the manuscripts may be so poorly written that the reviewers reject them straight away. My biggest piece of advice to anyone whose English is a weakness is: please ask a fluent English speaker for help. There are several linguistic editing services available if you have no one in your vicinity to help and it really could make all the difference. Also, all researchers must keep practicing writing and seek feedback from experienced researchers. Even if the research is good it may be difficult to publish it if you do not present it well. 


Message from Hindawi:

Following feedback from our Editors, we decided to pilot Writefull, an AI-based platform that improves the language of scientific texts and enables authors to review and edit their use of written English prior to submission. The results from this trial are promising and we will be sharing them with you in the near future. Great work should not be restricted by unnecessary barriers, such as language barriers. 

This blog post is distributed under the Creative Commons Attribution License (CC-BY). The illustration is by Hindawi and is also CC-BY.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.